(no title)
BinaryIdiot | 6 years ago
I think the idea here is since both SARS and Covid-19 are part of the coronavirus type, a vaccine for SARS would make modification and rapid deployment of a Covid-19 vaccine significantly better.
Really, any existing coronavirus vaccine would have helped research efforts tremendously.
> SARS-COV-1 infected people for 2 years, then it was gone. There's certainly a chance that SARS-COV-2 disappears before a vaccine could make it to market.
Highly unlikely. SARS ended up infecting an order of magnitude less people _in its entire 2 year run_ than Covid-19.
We will have this virus around for at least 5+ years, possibly forever.
gpderetta|6 years ago
do we know that's the case? It seems to me that the bottleneck is testing, which need to be done specifically for each vaccine.
BinaryIdiot|6 years ago
K0SM0S|6 years ago
- Sars-1 and Sars-2 (COVID-19) are related enough to bear the same name, thus having researched a virus for the former would be incredibly informating to finding a virus for the latter.
- As it stands, we know so little in that regard that we do not know if there is a possible vaccine for COVID-19. If I take an average between 3-10 years (the range of guesstimates floating around in some circles apparently), that's 2026-7 to have a definitive answer on that (it also depends a lot on the behavior of the virus, and we are only 10 weeks into this mess, we just don't know).
- human testing on Sars-1 may have been impossible or rather unethical, but models on animal species are just about the way we do it for everything all the time, so having a 15-year body of research + associated datasets would have been the reasonable, cautious thing to do. Having a vaccine for e.g. mice on Sars-1 available now would help a lot.
- There is no valid reason to have stopped Sars-1 vaccine research, especially given the fact that numerous experts were certain that new coronaviruses would cross again to the human race in the future (this is still true today).
- Because of all this, we are now forced to rush tests on "best guesses" for vaccines, with nowhere near enough data to make a really "educated" guess, far from the usual. Meaning, increased risk to the patients in those trials, but most dramatically for all: we have cornered ourselves into making moonshots in a hurry in the quest for a vaccine.
There is a possibility that we've gotten so good at molecular biology and modelling that we'll actually overcome these obstacles that we've created for ourselves, but the gist is that had we been a little more forward-thinking (including hoarding stocks for medical supplies, etc), the ultimate death count could have been orders of magnitude smaller, possibly anecdotal.